Definitive Healthcare (NASDAQ:DH) versus Firefly Neuroscience (NASDAQ:AIFF) Financial ComparisonDefense World · Oct 4, 2026
Firefly Neuroscience and Neurosigma Partner To Expand Non-Drug Pediatric ADHD CareBenzinga · Sep 25, 2026
Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHDGlobeNewsWire · Sep 25, 2026
Firefly Neuroscience's Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial's AI-Native Operating System for Brain MedicineGlobeNewsWire · Sep 17, 2026
Firefly Neuroscience (NASDAQ:AIFF) vs. Pro Medicus (OTCMKTS:PMCUF) Head-To-Head AnalysisDefense World · Aug 12, 2026
Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan VolumesGlobeNewsWire · Aug 5, 2026Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions.